Multiple Myeloma Research Network
Facilitating Multiple Myeloma Research to Improve Clinical Outcomes
Multiple Myeloma Research Network
The ASH Research Collaborative® (ASH RC) Multiple Myeloma Research Network (MM Network) was launched to foster collaborative partnerships, accelerate research, and improve outcomes for individuals with multiple myeloma by advancing treatment development and generating evidence to support clinical decisions and care.
The MM Network and its partners share a commitment to:
- Build relationships with the myeloma community.
- Promote high-quality multi-center research and support collaboration among Network investigators.
- Leverage the power of real-world evidence through a centralized data repository (the ASH RC Data Hub).
- Connect industry sponsors with research-ready sites.
- Focus on research opportunities that hold the most promise for individuals living with multiple myeloma.
Multiple Myeloma Network Sites
The MM Network consists of 12 academic medical centers located in the United States.
- Atrium Health
- Barbara Ann Karmanos Cancer Institute
- Dana-Farber Cancer Institute
- Emory University School of Medicine
- Icahn School of Medicine at Mount Sinai (Tisch Cancer Institute)
- Mayo Clinic
- Medical College of Wisconsin
- Memorial Sloan Kettering Cancer Center
- UNC Medical Center
- University of California Davis
- University of California San Francisco
- Washington University School of Medicine in St. Louis
ASH RESEARCH COLLABORATIVE
The ASH Research Collaborative (ASH RC) is a non-profit organization established by the American Society of Hematology (ASH) in 2017 to improve the lives of people affected by blood diseases by fostering collaborative partnerships to accelerate progress in hematology. Learn more about ASH RC